These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1169 related items for PubMed ID: 19170237

  • 1. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 2. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
    Liao WT, Song LB, Zhang HZ, Zhang X, Zhang L, Liu WL, Feng Y, Guo BH, Mai HQ, Cao SM, Li MZ, Qin HD, Zeng YX, Zeng MS.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):508-14. PubMed ID: 17255272
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 15; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 4. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 5. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS, Han J, Shim YM, Park J, Kim DH.
    Cancer; 2005 Nov 01; 104(9):1825-33. PubMed ID: 16177988
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma.
    Chang H, Iizasa T, Shibuya K, Iyoda A, Suzuki M, Moriya Y, Liu TL, Hiwasa T, Hiroshima K, Fujisawa T.
    Cancer; 2004 Apr 15; 100(8):1665-72. PubMed ID: 15073855
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 15; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K.
    Cancer; 2003 Sep 01; 98(5):1008-13. PubMed ID: 12942569
    [Abstract] [Full Text] [Related]

  • 9. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 10. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 01; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y.
    Cancer; 2006 Jul 01; 107(1):154-61. PubMed ID: 16721818
    [Abstract] [Full Text] [Related]

  • 12. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L, Mei TH, Zhou XD, Zhang XG.
    Ai Zheng; 2009 Jan 01; 28(1):60-3. PubMed ID: 19448419
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R, Geng J, Wang JH, Chu XY, Geng HC, Chen LB.
    Lung Cancer; 2009 Nov 01; 66(2):237-44. PubMed ID: 19261348
    [Abstract] [Full Text] [Related]

  • 14. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May 01; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

  • 15. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
    Chen TF, Jiang GL, Fu XL, Wang LJ, Qian H, Wu KL, Zhao S.
    Lung Cancer; 2007 Apr 01; 56(1):105-14. PubMed ID: 17166620
    [Abstract] [Full Text] [Related]

  • 16. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
    Yuan K, Qian C, Zheng R.
    Med Sci Monit; 2009 Nov 01; 15(11):BR313-9. PubMed ID: 19865048
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
    Tran TA, Kallakury BV, Ambros RA, Ross JS.
    Cancer; 1998 Jul 15; 83(2):276-82. PubMed ID: 9669810
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS.
    Oncol Rep; 2006 Dec 15; 16(6):1205-10. PubMed ID: 17089038
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
    Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR.
    J Clin Oncol; 2004 Nov 15; 22(22):4575-83. PubMed ID: 15542809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.